- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Clear Cell Renal Cell Carcinoma in Netherlands
Total 674 results
-
Maastricht Radiation OncologyUniversity of PennsylvaniaCompletedNon Small Cell Lung CancerNetherlands
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedAdenocarcinoma | Esophageal Cancer | Squamous Cell Carcinoma | Gastro-esophageal Junction CancerNetherlands
-
UMC UtrechtUniversity Medical Center Groningen; Amsterdam UMC, location VUmc; The Netherlands... and other collaboratorsUnknownEsophageal Cancer | Esophageal Neoplasms | Esophageal Adenocarcinoma | Esophageal Squamous Cell CarcinomaNetherlands
-
PfizerCompletedRenal Cell CarcinomaUnited States, Australia, Canada, Spain, France, Italy, Korea, Republic of, Denmark, Germany, United Kingdom, Singapore, Netherlands, Austria, Sweden, Chile, Argentina, China, Finland, Hungary, Switzerland
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingUrothelial CarcinomaNetherlands
-
IpsenTerminatedGastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic TumoursUnited States, France, Belgium, Switzerland, Netherlands
-
UMC UtrechtUnknown
-
Novartis PharmaceuticalsCompletedRenal Cell CarcinomaCanada, United Kingdom, Hong Kong, Netherlands, United States, Thailand, Korea, Republic of, Spain, Australia, Denmark, Mexico, Germany, Turkey, Italy, France, Brazil, Peru, Taiwan, Argentina
-
Maastricht Radiation OncologyCompleted
-
Maastricht Radiation OncologyCompleted
-
PfizerCompletedRenal Cell CarcinomaFrance, Belgium, Hungary, Taiwan, United States, Australia, Spain, Hong Kong, Malaysia, Serbia, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Germany, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Russian Federation and more
-
PfizerCompletedKidney Neoplasms | Carcinoma, Renal CellUnited States, Australia, Netherlands, Canada, Czech Republic, Poland, Russian Federation, Slovakia, Sweden, Turkey, Ukraine, Serbia, Italy, Spain, United Kingdom, Greece, Taiwan, Argentina, Mexico, Latvia, Hungary, Former Serbia... and more
-
AO Innovation Translation CenterRecruitingMandibular Reconstruction | Segmental Mandibular DefectsGermany, Switzerland, United States, Netherlands, Sweden, Spain
-
ExelixisActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Taiwan, United...
-
The Netherlands Cancer InstituteAstraZenecaRecruitingOsimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. (OSIRIS)Non-small-cell Lung CarcinomaNetherlands
-
Radboud University Medical CenterAstraZenecaCompletedNon-small Cell Lung CancerNetherlands
-
Radboud University Medical CenterMerck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung CancerNetherlands
-
University of WarwickUniversity of Oxford; Cancer Research UK; University of BirminghamUnknownOropharyngeal Squamous Cell CarcinomaIreland, United Kingdom, Netherlands
-
The Netherlands Cancer Institute4SC AGActive, not recruitingUrothelial CarcinomaNetherlands
-
Radboud University Medical CenterUMC Utrecht; Amsterdam UMC, location VUmc; Maastro Clinic, The Netherlands; Rad...CompletedHead and Neck Neoplasms | Carcinoma, Squamous CellNetherlands
-
Maastricht University Medical CenterActive, not recruitingRecurrence | Surgery | Metastasis | Squamous Cell Carcinoma | Lip | Surgical Margin | Lip Cancer | Lip SCC | Squamous Cell Carcinoma of the Lip | Tumor Free MarginsNetherlands
-
The Netherlands Cancer InstituteRecruitingSquamous Cell Carcinoma of the Vulva | Locally Advanced Vulvar CarcinomaNetherlands
-
Merus N.V.Chiltern International Inc.; Q2 Solutions; Oncology Therapeutic Development (OTD) and other collaboratorsRecruitingGastric Cancer | Colorectal Cancer | NSCLC | Head and Neck Squamous Cell Carcinoma | HNSCC | Advanced/Metastatic Solid Tumors | Gastroesophageal-junction CancerUnited States, Spain, Belgium, France, Netherlands, United Kingdom
-
Maastricht Radiation OncologyWithdrawn
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedNon-small Cell Lung Carcinoma | Sarcoidosis | Mediastinal LymphadenopathyNetherlands
-
Radboud University Medical CenterTerminatedStage III Non-small Cell Lung Cancer | Individualized Radiation Dose EscalationNetherlands
-
Novartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States, Canada, Spain, United Kingdom, Taiwan, Netherlands, Australia, Germany, Italy, Japan, Sweden, China, Ireland, Korea, Republic of
-
PfizerApproved for marketingCarcinoma, Renal CellUnited States, Netherlands, Canada, Bulgaria, Czech Republic, Hungary, Spain, United Kingdom, Greece, Australia, Belgium, France, Germany, Italy, Panama, Russian Federation, Sweden, Brazil, Taiwan, Argentina, Mexico, Serbia, Thailand, Korea, Republic of and more
-
Maastricht Radiation OncologyCompleted
-
Maastricht Radiation OncologyAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Maastro...Completed
-
Maastricht Radiation OncologyMerck Sharp & Dohme LLC; Academisch Ziekenhuis MaastrichtCompleted
-
Novartis PharmaceuticalsRoche Pharma AGCompletedAdenocarcinoma | Carcinoma | Renal Cell | Nephroid Carcinoma | HypernephroidBelgium, Italy, Spain, United Kingdom, Germany, Taiwan, Turkey, Egypt, Hong Kong, Russian Federation, Switzerland, Thailand, France, Netherlands, Korea, Republic of, Brazil, United States, Czech Republic, South Africa, Hungary, ...
-
Eli Lilly and CompanyTerminatedSmall Cell Lung Cancer | SCLC | Carcinoma, Small CellNetherlands, Belgium
-
Maastricht Radiation OncologyCompletedStage I-III Non-small Cell Lung CancerNetherlands
-
Hoffmann-La RocheCompletedRenal Cell CancerItaly, Spain, Germany, Switzerland, Russian Federation, Czech Republic, France, United Kingdom, Belgium, Singapore, Hungary, Poland, Israel, Taiwan, Australia, Finland, Netherlands, Norway
-
Maastricht University Medical CenterRecruitingNon-small Cell Lung CancerNetherlands
-
Maastricht Radiation OncologyCompletedStage I-III Small Cell Lung CancerNetherlands
-
Erasmus Medical CenterRecruitingNon Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase InhibitorNetherlands
-
Frame Pharmaceuticals B.V.University Medical Center Groningen; Erasmus Medical Center; The Netherlands... and other collaboratorsNot yet recruiting
-
University Medical Center GroningenRecruitingNon Small Cell Lung Cancer MetastaticNetherlands
-
Radboud University Medical CenterUnknownCarcinoma, Non Small Cell LungNetherlands
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLCUnknownNon Small Cell Lung CancerNetherlands
-
Prelude TherapeuticsRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancers | SMARCA4 Gene MutationUnited States, France, Spain, Singapore, Netherlands
-
Maastricht Radiation OncologyCompletedNon-small Cell Lung CancerNetherlands
-
Maastricht Radiation OncologyAnticancer Fund, Belgium; Reliable Cancer TherapiesTerminatedNon Small Cell Lung Cancer (NSCLC)Netherlands
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands
-
Merck KGaA, Darmstadt, GermanyCompletedLung Cancer | Non Small Cell Lung CancerNetherlands
-
Commissie Voor Klinisch Toegepast OnderzoekUnknownLung CancerNetherlands
-
Maastricht Radiation OncologyUniversitaire Ziekenhuizen KU LeuvenCompletedNon Small Cell Lung CancerNetherlands, Belgium
-
University Medical Center GroningenRecruitingSpeech Disorders | Oral Cavity Squamous Cell CarcinomaNetherlands